Quote | Alzamend Neuro Inc. (NASDAQ:ALZN)
Last: | $0.42 |
---|---|
Change Percent: | -6.27% |
Open: | $0.424 |
Close: | $0.42 |
High: | $0.424 |
Low: | $0.3888 |
Volume: | 43,939 |
Last Trade Date Time: | 06/21/2024 03:00:00 am |
News | Alzamend Neuro Inc. (NASDAQ:ALZN)
2024-06-03 16:37:41 ET More on Alzamend Neuro Alzamend Neuro enters private placement of up to $25M Alzamend Neuro terminates at-the-market equity offering program Seeking Alpha’s Quant Rating on Alzamend Neuro Read the full article on Seeking Alpha ...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Message Board Posts | Alzamend Neuro Inc. (NASDAQ:ALZN)
Subject | By | Source | When |
---|---|---|---|
Short of a cure this goes nowhere | Roozy | investorshub | 04/03/2023 4:22:48 PM |
To date, I've made almost $10K trading the | PennyStockTrader2 | investorshub | 04/01/2023 1:33:33 PM |
BFnD!! | Roozy | investorshub | 03/24/2023 12:19:17 AM |
Gotta be for sale cheap!! | Roozy | investorshub | 03/17/2023 4:14:05 PM |
NO confidence vote here!! | Roozy | investorshub | 02/24/2023 8:38:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Alzamend Neuro Inc. Company Name:
ALZN Stock Symbol:
NASDAQ Market:
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...
On Thursday, Alzamend Neuro Inc (NASDAQ:ALZN) entered into a Securities Purchase Agreement with an institutional investor for the purchas...